Smith MS - Search Results

1

Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.

Smith MS, Kessler JA, Rankin CD, Pagano JS, Kurtzberg J, Carter SG. Smith MS, et al. Antimicrob Agents Chemother. 1993 Jan;37(1):144-7. doi: 10.1128/AAC.37.1.144. Antimicrob Agents Chemother. 1993. PMID: 8431013 Free PMC article.

2

Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.

Smith MS, Brian EL, Pagano JS. Smith MS, et al. J Virol. 1987 Dec;61(12):3769-73. doi: 10.1128/JVI.61.12.3769-3773.1987. J Virol. 1987. PMID: 2446006 Free PMC article.

3

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.

Smith MS, Brian EL, De Clercq E, Pagano JS. Smith MS, et al. Antimicrob Agents Chemother. 1989 Sep;33(9):1482-6. doi: 10.1128/AAC.33.9.1482. Antimicrob Agents Chemother. 1989. PMID: 2479334 Free PMC article.

4

Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. J Infect Dis. 1993 Feb;167(2):445-8. doi: 10.1093/infdis/167.2.445. J Infect Dis. 1993. PMID: 7678429

5

Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

Smith MS, Thresher RJ, Pagano JS. Smith MS, et al. Antimicrob Agents Chemother. 1991 Jan;35(1):62-7. doi: 10.1128/AAC.35.1.62. Antimicrob Agents Chemother. 1991. PMID: 1707604 Free PMC article.

6

Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. J Infect Dis. 1994 Jan;169(1):184-8. doi: 10.1093/infdis/169.1.184. J Infect Dis. 1994. PMID: 7506280 Clinical Trial.

7

Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy.

Smith MS, Koerber KL, Pagano JS. Smith MS, et al. Leukemia. 1994 Apr;8 Suppl 1:S179-82. Leukemia. 1994. PMID: 8152287

8

Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR.

Markovitz DM, Kenney S, Kamine J, Smith MS, Davis M, Huang ES, Rosen C, Pagano JS. Markovitz DM, et al. Among authors: smith ms. Virology. 1989 Dec;173(2):750-4. doi: 10.1016/0042-6822(89)90591-6. Virology. 1989. PMID: 2556854

9

Variation of HIV infectibility of macrophages as a function of donor, stage of differentiation, and site of origin.

Olafsson K, Smith MS, Marshburn P, Carter SG, Haskill S. Olafsson K, et al. Among authors: smith ms. J Acquir Immune Defic Syndr (1988). 1991;4(2):154-64. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1702834

10

Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.

Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seillier-Moiseiwitsch F, Swanstrom R. Shugars DC, et al. Among authors: smith ms. J Virol. 1993 Aug;67(8):4639-50. doi: 10.1128/JVI.67.8.4639-4650.1993. J Virol. 1993. PMID: 8043040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters